SEOUL, May 10 (Korea Bizwire) – The prevalence of ovarian cancer among South Korean women in their 20s has jumped nearly 50 percent over the past five years due to a change in their life patterns, data showed Sunday. According to the data by the Health Insurance Review & Assessment Service, 20-something ovarian cancer patients stood at 1,218 last year, [...]
SEOUL, July 25 (Korea Bizwire) – According to the National Health Insurance Service’s (NHIS) medical expenses report, the number of patients who were diagnosed with breast cancer in South Korea surged 36 percent from 104,293 in 2011 to 141,379 in 2015. “Early screening apparently improves the diagnosis rate of breast cancer. Even after the recurrence of [...]
UPPSALA, Sweden, Apr. 20 (Korea Bizwire) — Paclical, a novel formulation of paclitaxel based on Oasmia’s XR-17 technology, was approved for treatment of (i.e., it received market authorization for) epithelial ovarian cancer in combination with carboplatin. XR-17 is non-toxic and forms water soluble nanoparticles with paclitaxel. “After many years of significant efforts by everyone involved [...]